| Resident memory CD8+ T cells within cancer islands mediate survival in breast cancer patients CA Egelston, C Avalos, TY Tu, A Rosario, R Wang, S Solomon, ... JCI insight 4 (19), 2019 | 96 | 2019 |
| Investigating strain dependency in the production of aromatic compounds in Saccharomyces cerevisiae M Suástegui, W Guo, X Feng, Z Shao Biotechnology and Bioengineering 113 (12), 2676-2685, 2016 | 71 | 2016 |
| Mini-review: in vitro metabolic engineering for biomanufacturing of high-value products W Guo, J Sheng, X Feng Computational and Structural Biotechnology Journal 15, 161-167, 2017 | 67 | 2017 |
| Metabolic engineering of Saccharomyces cerevisiae to produce 1-hexadecanol from xylose W Guo, J Sheng, H Zhao, X Feng Microbial cell factories 15, 1-11, 2016 | 62 | 2016 |
| A phase II clinical trial of pembrolizumab and enobosarm in patients with androgen receptor‐positive metastatic triple‐negative breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... The oncologist 26 (2), 99-e217, 2021 | 59 | 2021 |
| Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... European Journal of Cancer 154, 11-20, 2021 | 44 | 2021 |
| 13C Pathway Analysis for the Role of Formate in Electricity Generation by Shewanella Oneidensis MR-1 Using Lactate in Microbial Fuel Cells S Luo, W Guo, K H. Nealson, X Feng, Z He Scientific reports 6 (1), 20941, 2016 | 40 | 2016 |
| DeepMetabolism: a deep learning system to predict phenotype from genome sequencing W Guo, Y Xu, X Feng arXiv preprint arXiv:1705.03094, 2017 | 28 | 2017 |
| OM-FBA: integrate transcriptomics data with flux balance analysis to decipher the cell metabolism W Guo, X Feng PloS one 11 (4), e0154188, 2016 | 28 | 2016 |
| Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor–positive breast cancer CA Egelston, W Guo, J Tan, C Avalos, DL Simons, MH Lim, YJ Huang, ... JCI insight 7 (3), 2022 | 25 | 2022 |
| Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive … C Egelston, W Guo, S Yost, JS Lee, D Rose, C Avalos, J Ye, P Frankel, ... Journal for Immunotherapy of Cancer 9 (3), 2021 | 22 | 2021 |
| Investigate the Metabolic Reprogramming of Saccharomyces cerevisiae for Enhanced Resistance to Mixed Fermentation Inhibitors via 13C Metabolic Flux Analysis W Guo, Y Chen, N Wei, X Feng PLoS One 11 (8), e0161448, 2016 | 20 | 2016 |
| 13C-Metabolic Flux Analysis: An Accurate Approach to Demystify Microbial Metabolism for Biochemical Production W Guo, J Sheng, X Feng Bioengineering 3 (1), 3, 2015 | 20 | 2015 |
| PD-L1 and ICOSL discriminate human secretory and helper dendritic cells in cancer, allergy and autoimmunity C Hoffmann, F Noel, M Grandclaudon, L Massenet-Regad, P Michea, ... Nature Communications 13 (1), 1983, 2022 | 17 | 2022 |
| Synergizing 13C Metabolic Flux Analysis and Metabolic Engineering for Biochemical Production W Guo, J Sheng, X Feng Synthetic Biology–Metabolic Engineering, 265-299, 2018 | 14 | 2018 |
| 13 C pathway analysis of biofilm metabolism of Shewanella oneidensis MR-1 W Guo, S Luo, Z He, X Feng RSC Advances 5 (50), 39840-39843, 2015 | 14 | 2015 |
| Investigating oxalate biosynthesis in the wood-decaying fungus Gloeophyllum trabeum using 13 C metabolic flux analysis L Zhuang, W Guo, M Yoshida, X Feng, B Goodell Rsc Advances 5 (126), 104043-104047, 2015 | 13 | 2015 |
| Genomic markers of CDK 4/6 inhibitor resistance in hormone receptor positive metastatic breast cancer JS Lee, SE Yost, SM Li, Y Cui, PH Frankel, YC Yuan, D Schmolze, ... Cancers 14 (13), 3159, 2022 | 10 | 2022 |
| Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer CA Egelston, W Guo, SE Yost, X Ge, JS Lee, PH Frankel, Y Cui, C Ruel, ... Cancer Immunology, Immunotherapy 72 (9), 3013-3027, 2023 | 9 | 2023 |
| Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade M Mei, L Chen, J Godfrey, J Song, C Egelston, S Puverel, LE Budde, ... Blood 142 (16), 1359-1370, 2023 | 8 | 2023 |
Xueyang FengSenior Director, Biology and Applications at Biolog Inc.在 vt.edu 的电子邮件经过验证
